SW756Homo sapiens (Human)Cancer cell line

Also known as: SW 756, SW-756

🤖 AI SummaryBased on 10 publications

Quick Overview

Human cervical carcinoma cell line with HPV18 integration

Detailed Summary

SW756 is a human cervical carcinoma cell line derived from a primary cervical carcinoma. It is known for its HPV18 integration, which has been mapped to chromosome 12. The cell line exhibits characteristics of squamous cell carcinoma and is used in research related to cervical cancer biology and HPV-associated malignancies. SW756 has been utilized in studies investigating the molecular mechanisms of HPV integration, its impact on cellular transformation, and the role of viral oncogenes in tumorigenesis. The cell line is also notable for its use in studies examining the relationship between HPV infection and cancer progression, as well as in the development of targeted therapies against HPV-driven cancers.

Research Applications

HPV integration studiesCervical cancer biologyViral oncogene functionTumorigenesis mechanismsTargeted therapy development

Key Characteristics

HPV18 integrationSquamous cell carcinoma originUsed in HPV-related cancer research
Generated on 6/17/2025

Basic Information

Database IDCVCL_1727
SpeciesHomo sapiens (Human)
Tissue SourceUterus, cervix[UBERON:UBERON_0000002]

Donor Information

Age46
Age CategoryAdult
SexFemale

Disease Information

DiseaseSquamous cell carcinoma of the cervix uteri
LineageCervix
SubtypeCervical Squamous Cell Carcinoma
OncoTree CodeCESC

DepMap Information

Source TypeATCC
Source IDACH-001402_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleKRASp.Gly12Cys (c.34G>T)Unspecified-PubMed=21173094

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
11
D16S539
12,13
D18S51
14,17
D21S11
30
D3S1358
15,17
D5S818
11,12
D7S820
10,12
D8S1179
11,13
FGA
20,22
Penta D
9,12
Penta E
11,12
TH01
9.3
TPOX
8
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Establishment, authenticity, and characterization of cervical cancer cell lines.

Garcia-Carranca A.M., Cerbon-Cervantes M.A., Alcantara-Quintana L.E.

Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines.

Frederick M.J., Myers J.N., Pickering C.R., Johnson F.M.

Oncotarget 8:86369-86383(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

Individual karyotypes at the origins of cervical carcinomas.";

Duesberg P.H.

Mol. Cytogenet. 6:44.1-44.23(2013).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Smad4 deficiency in cervical carcinoma cells.";

Schwarte-Waldhoff I.

Oncogene 24:810-819(2005).

Mutations of the BRAF gene in human cancer.";

Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.

Nature 417:949-954(2002).

Characterization of a cell line (SW756) derived from a human squamous carcinoma of the uterine cervix.

Gallager H.S., Giovanella B.C.

In Vitro 18:719-726(1982).

Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.

Wright W.C., Daniels W.P., Fogh J.

J. Natl. Cancer Inst. 66:239-247(1981).

Human tumor lines for cancer research.";

Fogh J.

Cancer Invest. 4:157-184(1986).

Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.

Durst M., Croce C.M., Gissmann L., Schwarz E., Huebner K.

Proc. Natl. Acad. Sci. U.S.A. 84:1070-1074(1987).

Analysis of established human carcinoma cell lines for lymphoreticular-associated membrane receptors.

Kerbel R.S., Pross H.F., Leibovitz A.

Int. J. Cancer 20:673-679(1977).

Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Fogh J., Wright W.C., Loveless J.D.

J. Natl. Cancer Inst. 58:209-214(1977).